Overview
Paola Llanos practices practicing medicine in Santiago, Chile.
Her clinical expertise encompasses Type B Insulin Resistance Syndrome, Obesity, and Muscle Atrophy.
She is actively involved in clinical research, co-authoring 39 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Paola Llanos
Is Paola Llanos a top-rated expert for Type B Insulin Resistance Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Paola Llanos is classified as an Experienced expert for Type B Insulin Resistance Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Paola Llanos participate in research or clinical trials?
Yes. Paola Llanos has published 39 articles and abstracts on conditions like Type B Insulin Resistance Syndrome. You can view a list of Paola Llanos's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Muscle AtrophyMs. Llanos isExperienced. Learn about Muscle Atrophy.
- ObesityMs. Llanos isExperienced. Learn about Obesity.
- Type B Insulin Resistance SyndromeMs. Llanos isExperienced. Learn about Type B Insulin Resistance Syndrome.